51 related articles for article (PubMed ID: 10992268)
1. Free radical formation and toxicity in the limb teratogenicity of L-NAME: a new mechanistic model of vascular disruption.
Fantel AG; Stamps LD; Tran TT; Mackler B; Person RE; Nekahi N
Teratology; 2000 Oct; 62(4):237. PubMed ID: 10992268
[No Abstract] [Full Text] [Related]
2. Role of free radicals in the limb teratogenicity of L-NAME (N(G)-nitro-(L)-arginine methyl ester): a new mechanistic model of vascular disruption.
Fantel AG; Stamps LD; Tran TT; Mackler B; Person RE; Nekahi N
Teratology; 1999 Sep; 60(3):151-60. PubMed ID: 10471900
[TBL] [Abstract][Full Text] [Related]
3. Further evidence for the role of free radicals in the limb teratogenicity of L-NAME.
Fantel AG; Person RE
Teratology; 2002 Jul; 66(1):24-32. PubMed ID: 12115777
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide donors prevent while the nitric oxide synthase inhibitor L-NAME increases arachidonic acid plus CYP2E1-dependent toxicity.
Wu D; Cederbaum A
Toxicol Appl Pharmacol; 2006 Oct; 216(2):282-92. PubMed ID: 16938321
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide scavenging by hydroxocobalamin may account for its hemodynamic profile.
Gerth K; Ehring T; Braendle M; Schelling P
Clin Toxicol (Phila); 2006; 44 Suppl 1():29-36. PubMed ID: 16990191
[TBL] [Abstract][Full Text] [Related]
6. Production of axial skeletal malformations with the nitric oxide synthesis inhibitor NG-nitro-L-arginine methyl ester (L-NAME) in the mouse.
Tiboni GM; Marotta F; Barbacane L
Birth Defects Res B Dev Reprod Toxicol; 2007 Feb; 80(1):28-33. PubMed ID: 17294455
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
[TBL] [Abstract][Full Text] [Related]
8. Effects of nitric oxide and peroxynitrite on endotoxin-induced leukocyte adhesion to endothelium.
Lelamali K; Wang W; Gengaro P; Edelstein C; Schrier RW
J Cell Physiol; 2001 Sep; 188(3):337-42. PubMed ID: 11473360
[TBL] [Abstract][Full Text] [Related]
9. Dietary Zn deficiency does not influence systemic blood pressure and vascular nitric oxide signaling in normotensive rats.
Sato M; Kurihara N; Moridaira K; Sakamoto H; Tamura J; Wada O; Yanagisawa H
Biol Trace Elem Res; 2003 Feb; 91(2):157-72. PubMed ID: 12719611
[TBL] [Abstract][Full Text] [Related]
10. Involvement of NO in the endothelium-independent relaxing effects of N(omega)-hydroxy-L-arginine and other compounds bearing a C=NOH function in the rat aorta.
Vetrovsky P; Boucher JL; Schott C; Beranova P; Chalupsky K; Callizot N; Muller B; Entlicher G; Mansuy D; Stoclet JC
J Pharmacol Exp Ther; 2002 Nov; 303(2):823-30. PubMed ID: 12388669
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
[TBL] [Abstract][Full Text] [Related]
12. Decrease in cochlear blood flow with infusion of nitric oxide synthase inhibitor and its recovery with L-arginine infusion: comparison with abdominal blood flow and auricular blood flow.
Hoshijima H; Makimoto K
Acta Otolaryngol; 2002 Dec; 122(8):808-15. PubMed ID: 12542197
[TBL] [Abstract][Full Text] [Related]
13. Effects of bulbus Fritillaria water extract on blood pressure and renal functions in the L-NAME-induced hypertensive rats.
Kang DG; Sohn EJ; Lee YM; Lee AS; Han JH; Kim TY; Lee HS
J Ethnopharmacol; 2004 Mar; 91(1):51-6. PubMed ID: 15036467
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of vascular nitric oxide after rat chronic brain hypoperfusion: spatial memory and immunocytochemical changes.
de la Torre JC; Aliev G
J Cereb Blood Flow Metab; 2005 Jun; 25(6):663-72. PubMed ID: 15703700
[TBL] [Abstract][Full Text] [Related]
15. EDHF-mediated rapid restoration of hypotensive response to acetylcholine after chronic, but not acute, nitric oxide synthase inhibition in rats.
Desai KM; Gopalakrishnan V; Hiebert LM; McNeill JR; Wilson TW
Eur J Pharmacol; 2006 Sep; 546(1-3):120-6. PubMed ID: 16876156
[TBL] [Abstract][Full Text] [Related]
16. Induction of small intestinal damage in rats following combined treatment with cyclooxygenase-2 and nitric-oxide synthase inhibitors.
Ohno R; Yokota A; Tanaka A; Takeuchi K
J Pharmacol Exp Ther; 2004 Aug; 310(2):821-7. PubMed ID: 15044560
[TBL] [Abstract][Full Text] [Related]
17. Anti-lipid deposition effect of HMG-CoA reductase inhibitor, pitavastatin, in a rat model of hypertension and hypercholesterolemia.
Kumai T; Oonuma S; Matsumoto N; Takeba Y; Taniguchi R; Kamio K; Miyazu O; Koitabashi Y; Sekine S; Tadokoro M; Kobayashi S
Life Sci; 2004 Mar; 74(17):2129-42. PubMed ID: 14969717
[TBL] [Abstract][Full Text] [Related]
18. Structure of cerebral arterioles in mice deficient in expression of the gene for endothelial nitric oxide synthase.
Baumbach GL; Sigmund CD; Faraci FM
Circ Res; 2004 Oct; 95(8):822-9. PubMed ID: 15388643
[TBL] [Abstract][Full Text] [Related]
19. Endothelial inhibitory modulation on the contractile responses to alpha 2-adrenergic agonists.
Gil-Gastelum O; Valencia I; Larios FJ; Castillo EF; Castillo C
Proc West Pharmacol Soc; 2002; 45():88-9. PubMed ID: 12434540
[No Abstract] [Full Text] [Related]
20. Pronounced hypothermic synergy between systemic baclofen and NOS inhibitor.
Rawls SM; Baron DA; Gomez T; Jacobs K; Tallarida RJ
Eur J Pharmacol; 2004 Oct; 502(3):271-2. PubMed ID: 15476754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
